Stock·NASDAQ·Industrials
Axon Enterprise, Inc. (AXON)
- Market cap
- $34.51B
- P/E
- 176.25
- Dividend yield
- None
- Street target
- $688.00median of 21 analysts
- 52-week range
- $339.01 $764.02
AXON stock forecast today
Where AXON stands today, and what CleaRank Financial AI makes of it.
AXON at a glance
Axon Enterprise, Inc. (AXON): Hold, 47/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($478.83 and $482.93).
- Earnings AXON beat estimates in 7 of its last 8 quarters, yet fell the next day after 1 of those beats.
- Insiders Insiders sold $203.0M and bought $1.0M over the last 18 months.
- Valuation P/E of 176.3 against 34.0 for the Industrials sector: a premium to peers (+418%).
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates Axon Enterprise, Inc. (AXON) Hold, with a model score of 47/100.
The analysts' outlook lifts the score most: 18 of 21 analysts rate it a buy and the median target is 62.0% above the price. The trend holds it back most: the price is 12.04% below its 200-day average and 11.29% below its 50-day average, and the 50-day average is 0.85% below the 200-day. The 50-day average stands at $478.83 and the 200-day at $482.93. Over the past year the price fell 42.28%.
Only on CleaRank
Figures we compute ourselves from AXON's own price, earnings and insider-filing history. Tap one to see it in context.
AXON stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $424.77 is 11.3% below the 50-day simple moving average of $478.83.Price above its 200-day average ›
The price is 12.0% below the 200-day simple moving average of $482.93.50-day average above the 200-day ›
The 50-day average ($478.83) is 0.9% below the 200-day average ($482.93), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 20% of its 52-week range, between $339.01 and $764.02.
AXON share price
Pick a period: each tab shows how far AXON has moved over it, to the last close.
Today's trading
Where AXON sits inside today's range and its 52-week range.
AXON fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/4P/E below the sector median ›
The trailing P/E of 176.25 is 418.4% above the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 10.72 is 168.0% above the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $199.3M on revenue of $3.2B, a net margin of 6.2%.Beat estimates in most recent reports ›
AXON beat the EPS estimate in 7 of its last 8 reports.
Key statistics
The headline figures for AXON.
As of October 26, 2026, AXON trades at $424.77, with a market value of $34.51B and a P/E ratio of 176.25.
What the numbers say
CleaRank Financial AI's reading of AXON's valuation, growth and risks.
Axon Enterprise, Inc. (AXON) carries a trailing P/E of 176.25, which is 418.4% above the Industrials median of 34.0. The peer comparison on this page puts the P/E at a premium to peers. On sales, the price-to-sales ratio of 10.72 is 168.0% above the sector median of 4.0. The company's market capitalisation stands at $34.5B.
AXON is growing faster than its sector. Revenue rose 35.30% in the latest quarter year on year, while the sector median stands at 11.7%. The company converts sales into a 6.19% net margin and a 5.17% operating margin. Return on equity is 6.22%, which is below the sector median of 17.8%. Finally, debt-to-equity sits at 0.50.
In its most recent report, on August 5, 2026, AXON reported EPS of $1.88. That result beat the analysts' figure by 2.17%. Even so, the share price fell 14.28% in the first session after the report.
The earnings record shows 7 beats in 8 reports, though the stock still fell in the first session after 1 of those 7 beats. The February 24, 2026 report stands out among the few before the latest: a beat of 34.38%, after which the stock rose 17.55%.
The P/E of 176.25, 418.4% above the sector median, puts AXON at a premium to peers, so weaker results would meet a higher bar. On a typical day the price of AXON shifts by 2.46%, the 30-day standard deviation of its daily returns with a beta of 1.44 against the S&P 500. Until the price regains its moving averages, the trend works against holders. The price is 44.40% below its 52-week high of $764.02.
AXON against the Industrials sector
How AXON compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: AXON trades at a significant premium to sector peers (+418%), suggesting market expectations for superior growth or market position.
Return vs XLI: Since May 14, 2025, AXON has lost 41.7% against a gain of 18.8% for XLI.
Performance against XLI
AXON and the Industrials sector fund over the same days.
Revenue and earnings
How much AXON sells, and how much of it becomes profit.
Revenue growth: Revenue grew 33.5% in FY2025 to $2.8B, from $2.1B a year earlier.
Profit margin: The net margin was 4.5% in FY2025, down from 18.1% the year before.
Profitable: AXON earned $125M in FY2025.
Earnings reality check
Did AXON beat what analysts expected, and how did the stock react?
Earnings record: AXON beat the analyst estimate in 7 of the last 8 quarters.
Market reaction: The stock fell in the first session after 1 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 5, 2026after close | $1.84 | $1.88 | +2.17% | -14.28% | -1.59% |
| May 6, 2026after close | $1.60 | $1.61 | +0.63% | +10.63% | -2.34% |
| Feb 24, 2026after close | $1.60 | $2.15 | +34.38% | +17.55% | +30.86% |
| Nov 4, 2025after close | $1.54 | $1.17 | -24.03% | -9.43% | -18.97% |
| Aug 4, 2025after close | $1.46 | $2.12 | +45.21% | +16.41% | +9.91% |
| May 7, 2025after close | $1.28 | $1.41 | +10.16% | +14.13% | +21.05% |
| Feb 25, 2025after close | $1.40 | $2.08 | +48.57% | +15.25% | +6.37% |
| Nov 7, 2024after close | $1.20 | $1.45 | +20.83% | +28.68% | +28.97% |
As of October 26, 2026, AXON has beaten the analyst EPS estimate in 7 of its last 8 reported quarters and fell in the first trading session after 1 of those beats; its latest report, on August 5, 2026, came in 2.17% above the estimate and the stock moved -14.28% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AXON AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 48.3, in neutral territory.RSI above 50 ›
An RSI of 48.3 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of AXON
The score, the reasoning behind it, and what could move the price next.
Axon Enterprise, Inc. (AXON) is trading in a downtrend. At $424.77, the stock sits 11.29% below its 50-day average of $478.83 and 12.04% below its 200-day average of $482.93. It is also near the floor of its 52-week range: the price is 25.30% above the 52-week low of $339.01 and 44.40% below the 52-week high of $764.02. Both averages point the same way, with the 50-day sitting 0.85% below the 200-day.
The price is down over each of these periods: 1.24% over the past month, 19.17% over the past three months and 42.28% over the past year. Volume in the last session ran 33.3% below its average, on a day the price rose 1.05%. The 14-day RSI of 48.3 is in the neutral zone, and the MACD line is negative.
Rating reaffirmed ›
Piper Sandler kept its Overweight rating on October 20, 2026.
Source: Analyst action, Piper Sandler, October 20, 2026
Earnings beat, but the stock fell ›
The August 5, 2026 report beat the EPS estimate by 2.17%, and the share price fell 14.28% in the first session after it.
Source: Earnings report, August 5, 2026
- The two closest levels to watch are the 50-day SMA at $478.83, which sits above the price, and the 20-day EMA at $419.69, which sits below it.
- The 14-day RSI reads 48.3, in the neutral zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- After the August 5, 2026 report the share price fell 14.28% in the first session; AXON beat estimates in 7 of the last 8 reports.
AXON sits below its 50-day and 200-day moving averages ($478.83 and $482.93), and that placement is why the trend reads down. Reclaiming the 50-day would be the first sign of a repair. The first level overhead is the 50-day SMA at $478.83.
The 20-day EMA at $419.69 is the next level beneath the price. The 14-day RSI reads 48.3, which places it in the neutral zone between 40 and 60.
Technical indicators
Momentum and trend for AXON, from its daily closes.
As of October 26, 2026, with AXON at $424.77, its 14-day RSI is 48.3 (neutral territory), its 50-day simple moving average is $478.83 and its 200-day is $482.93.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What AXON moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, AXON's 1-year correlation of daily returns is +0.35 with S&P 500 (SPY), +0.33 with Nasdaq 100 (QQQ), +0.20 with Bitcoin (BTC) and +0.02 with gold (XAU).
AXON price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
18 of 21 analysts rate it a buy or strong buy, 3 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $688.00 is 62.0% above the price.More buy ratings than three months ago ›
18 of 21 rate it a buy now, against 18 of 21 three months ago.
AXON Wall Street View
12-month price targets
The price, $424.77, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 20, 2026 | Piper Sandler | Maintains | Overweight |
| Sep 3, 2026 | Argus Research | Maintains | Buy |
| Aug 6, 2026 | UBS | Maintains | Neutral |
| Aug 6, 2026 | Morgan Stanley | Maintains | Overweight |
| Aug 6, 2026 | Piper Sandler | Maintains | Overweight |
| Aug 6, 2026 | Barclays | Maintains | Overweight |
As of October 26, 2026, 21 Wall Street analysts cover AXON: 18 rate it a buy or strong buy, 3 a hold and 0 a sell or strong sell. Their 12-month price targets range from $440.00 to $830.00. The median AXON price target is $688.00, 62.0% above the price of $424.77.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
AXON trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
AXON trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from AXON's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much AXON tends to move, against the market and on its own.
AXON price history and drawdowns
AXON's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 2.46% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 60.3%, from August 2025 to April 2026; the price is still 51.2% below that peak.Most 1-year holds ended higher ›
76% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $188,619, against $42,015 in the S&P 500 (SPY).
AXON Drawdowns & Recovery
As of October 26, 2026, AXON's worst peak-to-trough fall over the last 10 years with dividends reinvested was -60.3% (August 2025 to April 2026); it is still 51.2% below that peak, and 76% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into AXON in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: AXON beat the S&P 500 over this period: $188,619 against $42,015.
A $10,000 investment in AXON in October 2016 would be worth about $188,619 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to AXON, and which have not.
Strongest month, November: an average of +15.43%, up in 7 of 10 years.
Weakest month, March: an average of -3.76%, up in 5 of 10 years.
This month, October: has averaged +2.63%, up in 6 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, AXON's strongest calendar month has been November (average +15.43%, up in 7 of 10 years) and its weakest March (average -3.76%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
AXON stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in AXON, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in AXON today could grow to about $15,484 by 2030 in the base case, with a 90th-percentile outcome near $55,230 and a 10th-percentile outcome around $4,341. Projections are statistical simulations, not guarantees.
AXON Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $658 for AXON by 2030 in the base case, from $425 today (1.5x over 4 years). The 10th-percentile path ends near $184. These are outcomes of a Monte Carlo simulation run on AXON's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $251 | $474 | $895 | |
| 2028 | $215 | $529 | $1,299 | |
| 2029 | $196 | $590 | $1,774 | |
| 2030 | $184 | $658 | $2,346 |
Method: a lognormal simulation of AXON's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. AXON is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
AXON insider trading
What the people running the company have bought and sold.
AXON insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $1.0M on the open market and sold $203.0M.
As of October 26, 2026, AXON insiders reported 61 open-market sales worth $203.0M and 1 open-market purchase worth $1.0M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Isaiah Fields
Officer
|
Sell | 1.0K | $488.6K |
| Sep 8, 2026 | Patrick W. Smith
Chief Executive Officer
|
Sell | 10.0K | $5.1M |
| Aug 31, 2026 | Joshua M Isner
President
|
Sell | 16.8K | $9.6M |
| Aug 21, 2026 | Jeffrey C Kunins
Chief Technology Officer
|
Sell | 9.6K | $6.0M |
| Aug 14, 2026 | Brittany Bagley
Chief Operating Officer
|
Grant | 30.6K | - |
| Aug 14, 2026 | Cameron David Brooks
Officer
|
Grant | 15.8K | - |
| Aug 14, 2026 | Elizabeth Reid Coughlin
Officer
|
Grant | 6.8K | - |
| Aug 14, 2026 | Isaiah Fields
Officer
|
Grant | 10.5K | - |
| Aug 14, 2026 | Joshua M Isner
President
|
Grant | 82.1K | - |
| Aug 14, 2026 | Jeffrey C Kunins
Chief Technology Officer
|
Grant | 24.4K | - |
| Aug 14, 2026 | Jennifer H Mak
Officer
|
Grant | 3.9K | - |
| Aug 14, 2026 | Patrick W. Smith
Chief Executive Officer
|
Grant | 97.0K | - |
| Aug 7, 2026 | Patrick W. Smith
Chief Executive Officer
|
Sell | 9.9K | $5.4M |
| Aug 7, 2026 | Patrick W. Smith
Chief Executive Officer
|
Sell | 70 | $39.7K |
| Aug 5, 2026 | Brittany Bagley
Chief Operating Officer
|
Grant | 22.7K | - |
| Aug 5, 2026 | Cameron David Brooks
Officer
|
Grant | 2.5K | - |
| Aug 5, 2026 | Joshua M Isner
President
|
Grant | 78.2K | - |
| Aug 5, 2026 | Jeffrey C Kunins
Chief Technology Officer
|
Grant | 29.5K | - |
| Jul 8, 2026 | Vivek Mohindra
Director
|
Grant | 600 | - |
| Jul 7, 2026 | Patrick W. Smith
Chief Executive Officer
|
Sell | 10.0K | $6.4M |
| Jun 29, 2026 | Patrick W. Smith
Chief Executive Officer
|
Sell | 10.0K | $5.0M |
| Jun 5, 2026 | Joshua M Isner
President
|
Sell | 13.0K | $6.3M |
| Jun 4, 2026 | Patrick W. Smith
Chief Executive Officer
|
Sell | 20.0K | $10.0M |
| Jun 4, 2026 | Elizabeth Reid Coughlin
Officer
|
Sell | 1.6K | $753.7K |
| Jun 4, 2026 | Cameron David Brooks
Officer
|
Sell | 1.2K | $621.0K |
| Jun 2, 2026 | Brittany Bagley
Chief Operating Officer
|
Sell | 6.0K | $2.9M |
| Jun 1, 2026 | Jeri L Williams
Director
|
Sell | 629 | $295.4K |
| Jun 1, 2026 | Caitlin Elizabeth Kalinowski
Director
|
Sell | 564 | $270.1K |
| May 29, 2026 | Adriane M Brown
Director
|
Grant | 611 | - |
| May 29, 2026 | Michael Garnreiter
Director
|
Grant | 658 | - |
| May 29, 2026 | Caitlin Elizabeth Kalinowski
Director
|
Grant | 611 | - |
| May 29, 2026 | Todd R Morgenfeld
Director
|
Grant | 611 | - |
| May 29, 2026 | Erika Nardini
Director
|
Grant | 611 | - |
| May 29, 2026 | Hadi Partovi
Director
|
Grant | 611 | - |
| May 29, 2026 | Graham V Smith
Director
|
Grant | 611 | - |
| May 29, 2026 | Jeri L Williams
Director
|
Grant | 611 | - |
| May 22, 2026 | Isaiah Fields
Officer
|
Sell | 2.0K | $800.0K |
| Mar 17, 2026 | Erika Nardini
Director
|
Sell | 198 | $100.3K |
| Mar 17, 2026 | Jeri L Williams
Director
|
Sell | 157 | $76.9K |
| Mar 10, 2026 | Joshua M Isner
President
|
Sell | 34.6K | $18.5M |
| Mar 9, 2026 | Patrick W. Smith
Chief Executive Officer
|
Sell | 10.0K | $5.6M |
| Mar 9, 2026 | Cameron David Brooks
Officer
|
Sell | 1.2K | $690.5K |
| Mar 2, 2026 | Brittany Bagley
Chief Operating Officer
|
Sell | 4.3K | $2.4M |
| Mar 2, 2026 | Jennifer H Mak
Officer
|
Sell | 1.5K | $860.2K |
| Feb 27, 2026 | Isaiah Fields
Officer
|
Sell | 2.0K | $1.1M |
| Feb 27, 2026 | Caitlin Elizabeth Kalinowski
Director
|
Sell | 930 | $497.9K |
| Feb 25, 2026 | Patrick W. Smith
Chief Executive Officer
|
Sell | 10.0K | $5.0M |
| Jan 7, 2026 | Patrick W. Smith
Chief Executive Officer
|
Sell | 10.0K | $6.2M |
| Dec 19, 2025 | Jennifer H Mak
Officer
|
Sell | 1.1K | $680.4K |
| Dec 15, 2025 | Caitlin Elizabeth Kalinowski
Director
|
Grant | 180 | - |
| Dec 15, 2025 | Jennifer H Mak
Officer
|
Grant | 1.4K | - |
| Dec 11, 2025 | Brittany Bagley
Chief Operating Officer
|
Sell | 2.0K | $1.2M |
| Dec 8, 2025 | Joshua M Isner
President
|
Sell | 20.0K | $11.1M |
| Dec 8, 2025 | Patrick W. Smith
Chief Executive Officer
|
Sell | 10.0K | $5.5M |
| Dec 4, 2025 | Jennifer H Mak
Officer
|
Sell | 894 | $491.7K |
| Dec 4, 2025 | Jeri L Williams
Director
|
Sell | 100 | $55.1K |
| Dec 3, 2025 | Joshua M Isner
President
|
Sell | 2.0K | $1.1M |
| Dec 3, 2025 | Jennifer H Mak
Officer
|
Sell | 74 | $39.7K |
| Dec 2, 2025 | Jeffrey C Kunins
Chief Technology Officer
|
Sell | 1.8K | $969.0K |
| Nov 13, 2025 | Brittany Bagley
Chief Operating Officer
|
Grant | 30.6K | - |
| Nov 13, 2025 | Cameron David Brooks
Officer
|
Grant | 15.8K | - |
| Nov 13, 2025 | Joshua M Isner
President
|
Grant | 67.9K | - |
| Nov 13, 2025 | Jeffrey C Kunins
Chief Technology Officer
|
Grant | 20.6K | - |
| Nov 13, 2025 | Jennifer H Mak
Officer
|
Grant | 3.9K | - |
| Nov 13, 2025 | Patrick W. Smith
Chief Executive Officer
|
Grant | 97.0K | - |
| Nov 10, 2025 | Brittany Bagley
Chief Operating Officer
|
Sell | 2.5K | $1.5M |
| Nov 7, 2025 | Patrick W. Smith
Chief Executive Officer
|
Sell | 10.0K | $5.9M |
| Oct 7, 2025 | Patrick W. Smith
Chief Executive Officer
|
Sell | 10.0K | $7.1M |
| Sep 29, 2025 | Brittany Bagley
Chief Operating Officer
|
Sell | 5.0K | $3.6M |
| Sep 15, 2025 | Brittany Bagley
Chief Operating Officer
|
Sell | 870 | $672.7K |
| Sep 15, 2025 | Jennifer H Mak
Officer
|
Sell | 77 | $58.5K |
| Sep 11, 2025 | Jeri L Williams
Director
|
Sell | 100 | $75.3K |
| Sep 8, 2025 | Patrick W. Smith
Chief Executive Officer
|
Sell | 10.0K | $7.4M |
| Sep 3, 2025 | Jennifer H Mak
Officer
|
Sell | 75 | $54.3K |
| Aug 29, 2025 | Hadi Partovi
Director
|
Grant | 100 | - |
| Aug 29, 2025 | Jeri L Williams
Director
|
Grant | 100 | - |
| Aug 28, 2025 | Cameron David Brooks
Officer
|
Grant | 31.6K | - |
| Aug 28, 2025 | Todd R Morgenfeld
Director
|
Grant | 336 | - |
| Aug 15, 2025 | Joshua M Isner
President
|
Sell | 15.9K | $11.9M |
| Aug 14, 2025 | Jeffrey C Kunins
Chief Technology Officer
|
Sell | 7.9K | $5.9M |
| Aug 13, 2025 | Hadi Partovi
Director
|
Buy | 1.4K | $1.0M |
| Aug 11, 2025 | Patrick W. Smith
Chief Executive Officer
|
Sell | 10.0K | $8.3M |
| Aug 7, 2025 | Joshua M Isner
President
|
Sell | 2.5K | $2.2M |
| Aug 7, 2025 | Caitlin Elizabeth Kalinowski
Director
|
Sell | 580 | $505.2K |
| Jun 17, 2025 | Joshua M Isner
President
|
Sell | 905 | $702.6K |
| Jun 13, 2025 | Jennifer H Mak
Officer
|
Sell | 75 | $57.9K |
| Jun 4, 2025 | Michael Garnreiter
Director
|
Sell | 6.0K | $4.6M |
| Jun 3, 2025 | Michael Garnreiter
Director
|
Grant | 1.0K | - |
| May 30, 2025 | Cameron David Brooks
Officer
|
Sell | 3.0K | $2.2M |
| May 29, 2025 | Adriane M Brown
Director
|
Grant | 446 | - |
| May 29, 2025 | Julie Anne Cullivan
Director
|
Grant | 446 | - |
| May 29, 2025 | Michael Garnreiter
Director
|
Grant | 481 | - |
| May 29, 2025 | Caitlin Elizabeth Kalinowski
Director
|
Grant | 446 | - |
| May 29, 2025 | Matthew R Mcbrady
Director
|
Grant | 446 | - |
| May 29, 2025 | Erika Nardini
Director
|
Grant | 446 | - |
| May 29, 2025 | Hadi Partovi
Director
|
Grant | 446 | - |
| May 29, 2025 | Graham V Smith
Director
|
Grant | 446 | - |
| May 29, 2025 | Jeri L Williams
Director
|
Grant | 446 | - |
| May 21, 2025 | Joshua M Isner
President
|
Sell | 9.9K | $7.3M |
| May 19, 2025 | Caitlin Elizabeth Kalinowski
Director
|
Sell | 1.3K | $960.5K |
| May 14, 2025 | Matthew R Mcbrady
Director
|
Sell | 400 | $287.4K |
| May 13, 2025 | Brittany Bagley
Chief Operating Officer
|
Sell | 3.4K | $2.4M |
| May 13, 2025 | Caitlin Elizabeth Kalinowski
Director
|
Sell | 800 | $570.6K |
| May 12, 2025 | Joshua M Isner
President
|
Sell | 9.0K | $6.1M |
| May 12, 2025 | Julie Anne Cullivan
Director
|
Sell | 657 | $459.9K |
Source: TwelveData, from SEC Form 4 filings
AXON stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.